Nafisa Wara is a medical student at the University of California, Los Angeles (UCLA) David Geffen School of Medicine. Ms. Wara is passionate about using implementation science to inform the integration of preventive sexual and reproductive care for people of reproductive age in resource-limited settings. She graduated from Harvard University in 2019 and pursued postgraduate research in Durban, South Africa, where she worked with the AIDS Healthcare Foundation South Africa and Massachusetts General Hospital on the design and evaluation of community-based delivery models of HIV prevention and sexual health care. These years inspired her current work assessing the feasibility and acceptability of long-acting PrEP modalities (e.g., injectable cabotegravir, dapivirine vaginal ring) among pregnant and lactating people, on which she has collaborated with researchers at UCLA, the University of Cape Town (UCT), the University of Washington, and Kenyatta National Hospital (Kenya).
Project
Development of patient-centered decision support to improve pre-exposure prophylaxis (PrEP) decision-making among pregnant and lactating people in Cape Town, South Africa
Despite high reported rates of daily oral pre-exposure prophylaxis (PrEP) uptake among pregnant and lactating people (PLP) in South Africa, individuals have reported substantial logistical and sociocultural barriers to adherence on daily oral PrEP. Long-acting PrEP modalities (e.g., eight-week injectable cabotegravir and four-week dapivirine vaginal ring) may mitigate barriers to adherence and persistence, and recent data show both high theoretical acceptability of injectable cabotegravir as PrEP among PLP, as well as continued interest by some in daily oral PrEP. With the approval and impending rollout of long-acting PrEP modalities in South Africa, there is an urgent need to integrate strategies that support PLP in choosing between PrEP modalities. Ms. Wara’s project will use mixed methods to engage with PLP and healthcare workers to inform the pre-implementation development of a patient-centered decision-support model for PrEP modality selection among PLP in Cape Town, South Africa.
Mentors: Risa Hoffman (UCLA), Dvora Joseph Davey (Desmond Tutu Health Foundation/UCT), Catherine Orrell (Desmond Tutu Health Foundation/UCT)
nwara@mednet.ucla.edu